Philanthropy

The following philanthropic priorities and public causes are proudly supported by J. Kyle Bass and Hayman Capital Management, L.P.:

Our Troops

Mr. Bass serves on the Board of Directors for the Troops First Foundation. The organization works to provide meaningful assistance to our military who have been wounded while serving in Iraq and Afghanistan. In support of today’s combat-wounded military personnel, Mr. Bass and the Troops First Foundation promote, operate and develop a synergistic group of wellness, quality of life and event-based initiatives. Through several relevant and unduplicated programs along with specialized events designed for service members and their families, Troops First addresses relationship building, mentoring and reintegration.

Education

Mr. Bass serves on the Board of Directors for the University of Texas Investment Management Company (UTIMCO), the largest public university endowment in the United States. He also serves the University of Virginia Darden School of Business Advisory Group for the Richard A. Mayo Center for Asset Management, a research center that advances the study and practice of asset management. As an advocate for educational development, Mr. Bass regularly collaborates with academic institutions to provide students with a spectrum of knowledge, skills and resources.

Mr. Bass has been featured as a guest speaker at several universities, including:

⋅   Harvard Business School

⋅   Columbia University

⋅   University of Chicago Booth School of Business

⋅   University of Texas

⋅   University of Virginia Darden School of Business

⋅   Texas Christian University

Healthcare

Mr. Bass seeks to raise awareness for the high prices consumers pay for medicines in the United States and how drug companies abuse the patent system to maintain anticompetitive, high-price monopolies. In 2015, Mr. Bass filed two patent challenges on a not-for-profit basis. Through these efforts, Mr. Bass seeks to eliminate improperly granted pharmaceutical patents to promote competition and innovation, which ultimately benefits consumers, taxpayers and American suffering from illness.